22-Mar-2022 Update:
As you are likely aware, the updated Medcheck report is delayed. This delay is extending past the estimated 8 weeks initially envisioned. We are anticipating a further 2-3 week delay.
***
MedCheck Temporarily Unavailable
In our efforts to always stay true to our "best in test" philosophy, we are in the process of upgrading the medcheck report with a new reporting partner. Unfortunately, the onboarding process has taken a little longer than expected, hence this test is currently unavailable.
We look forward to bringing you a new and improved version of this test as soon as possible.
***
The Medcheck® report provides practitioners with detailed guidelines on gene-drug interactions; highlighting potential side effects, increased toxicity, and lack of efficacy.
President Barack Obama stated in 2015
“What if figuring out the right dose of medicine was as simple as taking our temperature? That’s the promise of precision medicine. Delivering the right treatments, at the right time, every time to the right person”
Nordic Laboratories is committed to deliver on Barack Obama's vision. The Future of Healthcare is now.
The study of the relationship between genes and response to drugs has been the subject of intensive research over the past two decades. Robust evidence now exists to support testing under clinical conditions.
The Medcheck pharmacogenomics test is part of the dnalife® portfolio of genetic tests. We analyse genotypes associated with drug responsiveness for cardiovascular disease, psychiatry and pain management amongst others. Reports provide practitioners with detailed guidelines on gene-drug interactions; highlighting potential side effects, increased toxicity, and lack of efficacy.